Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4591212014 | MET (mesenchymal epithelial transition) inhibitor | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 4591213016 | Mesenchymal epithelial transition inhibitor | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4591214010 | Substance with mesenchymal epithelial transition inhibitor mechanism of action (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Mesenchymal epithelial transition inhibitor | Is a | Antineoplastic agent (substance) | true | Inferred relationship | Some | ||
| Mesenchymal epithelial transition inhibitor | Is a | Protein-tyrosine kinase inhibitor | true | Inferred relationship | Some | ||
| Mesenchymal epithelial transition inhibitor | Is a | Enzyme inhibitor | false | Inferred relationship | Some | ||
| Mesenchymal epithelial transition inhibitor | Has disposition (attribute) | Mesenchymal epithelial transition inhibitor | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Amivantamab (substance) | Is a | True | Mesenchymal epithelial transition inhibitor | Inferred relationship | Some | |
| Capmatinib (substance) | Is a | True | Mesenchymal epithelial transition inhibitor | Inferred relationship | Some | |
| Tepotinib | Is a | True | Mesenchymal epithelial transition inhibitor | Inferred relationship | Some | |
| Tepotinib hydrochloride | Is a | True | Mesenchymal epithelial transition inhibitor | Inferred relationship | Some |
This concept is not in any reference sets
FHIR